Corebridge Financial’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,523
Closed -$1.48M 103
2025
Q1
$1.48M Buy
36,523
+2,817
+8% +$114K 0.01% 1103
2024
Q4
$938K Sell
33,706
-2,544
-7% -$70.8K 0.01% 1354
2024
Q3
$1.04M Sell
36,250
-223
-0.6% -$6.4K 0.01% 1343
2024
Q2
$856K Buy
+36,473
New +$856K ﹤0.01% 1410